0001973379-24-000376.txt : 20241210 0001973379-24-000376.hdr.sgml : 20241210 20241210171657 ACCESSION NUMBER: 0001973379-24-000376 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20241210 DATE AS OF CHANGE: 20241210 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Ascendis Pharma A/S CENTRAL INDEX KEY: 0001612042 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: G7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-36815 FILM NUMBER: 241539409 BUSINESS ADDRESS: STREET 1: TUBORG BOULEVARD 12 CITY: HELLERUP STATE: G7 ZIP: DK-2900 BUSINESS PHONE: 45 70 22 22 44 MAIL ADDRESS: STREET 1: TUBORG BOULEVARD 12 CITY: HELLERUP STATE: G7 ZIP: DK-2900 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: SINGEL STINA CENTRAL INDEX KEY: 0001965496 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O ASCENDIS PHARMA A/S STREET 2: TUBORG BOULEVARD 12 CITY: HELLERUP STATE: G7 ZIP: DK-2900 144 1 primary_doc.xml 144 0001965496 XXXXXXXX LIVE 0001612042 Ascendis Pharma A/S 001-36815 TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44 SINGEL STINA Officer Executive Vice President, Head of Clinical Develop American Depository Shares Citi Group Global Market Inc.

390 Greenwich Street New York NY 10013

2119 273620.96 57345613 12/10/2024 NASDAQ American Depository Shares 12/10/2024 Restricted/Performance Stock Vesting Ascendis Pharma A/S N 2119 12/10/2024 Services Rendered Y Under securities to be sold, date acquired and date of payment are various 12/10/2024 Conformed Signature on File